Bristol-Myers Wins Patent Fight Over Generic HIV Drug
A Delaware federal judge on Tuesday handed victory to Bristol-Myers Squibb Co. in its battle to assert its patent on its HIV treatment Sustiva against generic drugmakers Mylan Pharmaceuticals Inc. and...To view the full article, register now.
Already a subscriber? Click here to view full article